Listed

Standard Biotools Inc.: Form 10-Q for the period ended Jun 30, 2016

Filed with the SEC on Aug 9, 2016 and accepted by EDGAR at Aug 8, 2016, 21:28 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2016-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2016-04-01 to 2016-06-30$28.2mus-gaap:Revenues
Revenue6 months2016-01-01 to 2016-06-30$57.2mus-gaap:Revenues
Cost of revenue3 months2016-04-01 to 2016-06-30$11.2mus-gaap:CostOfGoodsSold
Cost of revenue6 months2016-01-01 to 2016-06-30$22.0mus-gaap:CostOfGoodsSold
Research and development3 months2016-04-01 to 2016-06-30$10.0mus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2016-01-01 to 2016-06-30$20.4mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2016-04-01 to 2016-06-30$23.8mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2016-01-01 to 2016-06-30$49.3mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2016-04-01 to 2016-06-30−$18.1mus-gaap:OperatingIncomeLoss
Operating income6 months2016-01-01 to 2016-06-30−$37.0mus-gaap:OperatingIncomeLoss
Interest expense3 months2016-04-01 to 2016-06-30$1.5mus-gaap:InterestExpense
Interest expense6 months2016-01-01 to 2016-06-30$2.9mus-gaap:InterestExpense
Income tax3 months2016-04-01 to 2016-06-30−$1.0mus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2016-01-01 to 2016-06-30−$1.8mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2016-04-01 to 2016-06-30−$18.6mus-gaap:NetIncomeLoss
Net income6 months2016-01-01 to 2016-06-30−$38.5mus-gaap:NetIncomeLoss
Diluted EPS3 months2016-04-01 to 2016-06-30−$0.64us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS6 months2016-01-01 to 2016-06-30−$1.33us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow6 months2016-01-01 to 2016-06-30−$15.1mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2016-01-01 to 2016-06-30$2.7mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2016-06-30$35.9mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2016-06-30$127.0mus-gaap:AssetsCurrent
Total assetsAt period end2016-06-30$342.0mus-gaap:Assets
Current liabilitiesAt period end2016-06-30$32.3mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2016-06-30$257.8mus-gaap:Liabilities
Shareholders' equityAt period end2016-06-30$84.3mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001162194-16-000224. Last ingested by Listed: Nov 5, 2026, 21:16 ET. Listed shows no prices and gives no investment advice.